The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Drug: fluorouracil     Quarter: 2016Q3

Total Drug/Injury Combinations: 762     Number of Pages: 39

DRUGNAME PT EventCount
FLUOROURACIL. Dyspnoea 15 view events
FLUOROURACIL. Ill-defined disorder 15 view events
FLUOROURACIL. Cutaneous tuberculosis 14 view events
FLUOROURACIL. Eating disorder 14 view events
FLUOROURACIL. Hypokalaemia 14 view events
FLUOROURACIL. Hyponatraemia 14 view events
FLUOROURACIL. Malignant neoplasm progression 14 view events
FLUOROURACIL. Paraesthesia 14 view events
FLUOROURACIL. Coma 13 view events
FLUOROURACIL. Hyperammonaemic encephalopathy 13 view events
FLUOROURACIL. Intestinal obstruction 13 view events
FLUOROURACIL. Lethargy 13 view events
FLUOROURACIL. Muscular weakness 13 view events
FLUOROURACIL. Treatment failure 13 view events
FLUOROURACIL. Arthralgia 12 view events
FLUOROURACIL. Deep vein thrombosis 12 view events
FLUOROURACIL. Dysarthria 12 view events
FLUOROURACIL. Ear pain 12 view events
FLUOROURACIL. Feeling abnormal 12 view events
FLUOROURACIL. General physical health deterioration 12 view events

Total Drug/Injury Combinations: 762     Number of Pages: 39

NOTE: EventCount numbers on this page include duplicate entries from event reports. (e.g. One event has DrugX entered twice, which equals 2 on this page.) The "view events" page treats these duplicates as single entries. (e.g. The 2 entries of DrugX for a single event are counted as 1 instance.)